RBC Capital raised the firm’s price target on CyberArk (CYBR) to $481 from $410 and keeps an Outperform rating on the shares. The company posted a strong quarter with all metrics and initial 2025 guidance coming in ahead of consensus, the analyst tells investors in a research note. CyberArk’s Venafi integration is also tracking well after its first quarter, and RBC continues to believe there is upside to estimates throughout the year on an organic and inorganic basis as the Venafi cross-sell motion/product integration matures, the firm added.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYBR: